Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morris, D. R.
Right arrow Articles by Hager, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morris, D. R.
Right arrow Articles by Hager, L. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mechanism of the Inhibition of Enzymatic Halogenation by Antithyroid Agents

David R. Morris 1 and Lowell P. Hager 1

From the 1 From the Biochemistry Division, Department of Chemistry and Chemical Engineering, University of Illinois, Urbana, Illinois 61803

Antithyroid agents of the thiourea type (thiourea, thiouracil, and 5-vinyl-2-oxazolidinethione) inhibit the enzymatic halogenation reactions catalyzed by chloroperoxidase. These compounds are competitive with the halogen acceptor molecule and serve as substrates for chloroperoxidase. These antithyroid agents are oxidized by chloroperoxidase in the presence of hydrogen peroxide and a suitable halogen anion (chloride, bromide, or iodide).

The first isolable oxidation product of thiourea and thiouracil is the corresponding disulfide. It is proposed that a sulfenyl halide is a precursor of the disulfide.

Spectral evidence indicates the formation of an intermediate in the oxidation of 5-vinyl-2-oxazolidinethione. This intermediate is postulated to be a disulfide by analogy to the thiourea and thiouracil oxidations.

The goitrogen 1,1,3-tricyano-2-amino-1-propene serves as a halogen acceptor in the chloroperoxidase reaction.

Chloroperoxidase catalyzes the hydrogen peroxide-dependent oxidation of thiocyanate. Thiocyanate oxidation does not require the presence of a halogen anion. Cyanide ion is one of the oxidation products.

Thiocyanate ion inhibits the enzymatic halogenation reactions catalyzed by chloroperoxidase in a manner which is noncompetitive with respect to other chloroperoxidase substrates.

It is proposed that antithyroid agents containing the thiourylene group or related structures inhibit enzymatic halogenation reactions by virtue of being extremely active nucleophiles and thus capable of reacting with an enzyme-bound halogenium ion.

Submitted on February 28, 1966


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. F. Muller, H. A. Drexhage, and A. Berghout
Postpartum Thyroiditis and Autoimmune Thyroiditis in Women of Childbearing Age: Recent Insights and Consequences for Antenatal and Postnatal Care
Endocr. Rev., October 1, 2001; 22(5): 605 - 630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1966 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement